Jenis prosedur bedah apa yang dilakukan Tn. Chaudry berspesialisasi dalam?

Tn. Chaudry berspesialisasi dalam Bedah Kanker Esofagus & Kanker Lambung Robotik dan Laparoskopi, Bedah Invasif Minimal, Bedah Laparoskopi dan Robotik, Endoskopi, Bedah Umum, Bedah GI, Bedah Hernia, Bedah Darurat.

Apa itu mr. Peran Chaudry dalam penelitian dan publikasi?

Tn. Chaudry berfungsi sebagai timah onkologi bedah atau co-investigator untuk berbagai uji coba penelitian dan merupakan editor publikasi terhormat di lapangan, termasuk onkologi bedah, EPCAM dalam ensiklopedia kanker, dan bedah lambung dan esofagus Oesofagus.

Dimana Pak. Chaudry berafiliasi dengan?

Tn. Chaudry berafiliasi dengan Rumah Sakit Royal Marsden di Chelsea, Rumah Sakit Princess Grace, dan Klinik Harley St.

Apa saja gejala umum yang mungkin menunjukkan perlunya berkonsultasi dengan MR. Chaudry?

Gejala umum yang mungkin mengindikasikan perlunya berkonsultasi dengan Tn. Chaudry termasuk kesulitan menelan dan sakit perut.

Apa itu mr. Latar belakang pendidikan Chaudry?

Tn. Chaudry lulus dengan perbedaan dari Universitas Oxford dan menerima pelatihan di Oxford, London, dan Seoul.

Yang unik dari Pak. Pendekatan Chaudry terhadap operasi kanker esofagus?

Tn. Chaudry memimpin tim perintis di Inggris untuk bedah kanker esofagus robot, memanfaatkan sistem robot Da Vinci Xi terbaru.

Apa pentingnya MR. Pelatihan Chaudry di Seoul?

Tn. Chaudry mengembangkan keterampilannya di sebuah pusat di Seoul yang melakukan operasi kanker lambung dengan volume tertinggi di seluruh dunia.

Apa pentingnya MR. Pelatihan Chaudry di Utrecht?

Tn. Chaudry menerima pelatihan di bawah bimbingan Prof Richard Van Hillegersberg di Utrecht, Belanda, dan menjadi mahir dalam Bedah Kanker Oesofagus Robotik.

Apa peran tim kanker multi-profesional yang disampaikan oleh Tn. Chaudry berkolaborasi dengan?

Tim kanker multi-profesional bekerja sama dengan Mr. Chaudry untuk memberikan perawatan berkualitas tinggi dengan standar internasional, memastikan manajemen pasien yang komprehensif dan multi-disipliner.

M Asif Chaudry

Dokter Bedah Umum

Konsultasikan di:

Rumah Sakit Princess Grace, bagian dari HCA Healthcare UK

Operasi

N/A

Pengalaman

24+ bertahun-tahun

Tentang

Mr. Asif Chaudry is a British Surgical Oncologist renowned for his expertise in Oesophageal and Gastric Cancer. He collaborates closely with a team of medical and clinical oncologists, as well as a multi-professional cancer team, to deliver high quality care at an international standard. Mr. Chaudry is committed to innovation in his field and leads the pioneering team in the UK for Robotic Oesophageal Cancer Surgery utilising the latest Da Vinci Xi Robot system. Additionally, he has extensive experience in conventional laparoscopic (keyhole) surgery.

Currently affiliated with the Royal Marsden Hospital in Chelsea, Mr. Chaudry operates within a world-renowned centre of excellence for cancer care and treatment. This hospital, together with the Institute of Cancer Research, forms the largest comprehensive cancer centre in Europe. He also consults with patients at the Princess Grace Hospital and Harley St Clinic.

Mr. Chaudry pursued his education at Wadham College, Oxford, where he earned a scholarship and graduated with Distinction from Oxford University. His training spans Oxford, London, and Seoul, where he developed his skills at a centre performing the highest volume of gastric cancer operations worldwide. Proficient in Robotic Oesophageal Cancer Surgery, Mr. Chaudry received training under Prof Richard Van Hillegersberg in Utrecht, Netherlands.

With a focus on advancing cancer treatment, Mr. Chaudry serves as the Surgical Oncology lead or co-investigator for various research trials. He is also an editor of esteemed publications in the field, including the Surgical Oncology (Oxford University Press) EpCAM in the Encyclopedia of Cancer (Springer), and Gastric and Oesophageal Surgery (Oxford University Press). Moreover, he chaired cancer drug development sessions at notable conferences, including the International Drug Discovery Science and Technology Conference in Xian, China, and the World Cancer Congress in Singapore.